Cary Street Partners Asset Management LLC Acadia Pharmaceuticals Inc Transaction History

Cary Street Partners Asset Management LLC

  • $687 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$19.4 - $27.42 $326,696 - $461,752
-16,840 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$25.02 - $54.99 $292,608 - $643,108
-11,695 Reduced 40.98%
16,840 $17,000
Q4 2020

Feb 11, 2021
BUY
$41.04 - $56.79 $1.17 Million - $1.62 Million
28,535 New
28,535 $642,000

Others Institutions Holding ACAD

# of Institutions
279
Shares Held
156M
Call Options Held
901K
Put Options Held
314K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Cary Street Partners Asset Management LLC Portfolio

Follow Cary Street Partners Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email